FDA Approves Blincyto to Treat Rare Form of Leukemia
The U.S. Food and Drug Administration today approved Blincyto (blinatumomab) to treat patients with Philadelphia chromosome-negative precursor B-cell acute lymphoblastic leukemia (B-cell ALL), an uncommon form of ALL.
Immune Diseases Were More Common in Those Born by C-Section
Could the birth process have a role in immune disease development? A common birthing method may raise babies' risk of immune diseases later, a new study found.
FDA Approves Rx for Rare Type of Hemophilia
The US Food and Drug Administration (FDA) approved a new treatment Thursday for a rare form of hemophilia.
FDA Approves New Treatment for Rare Form of Hemophilia
The U.S. Food and Drug Administration yesterday approved Obizur [Antihemophilic Factor (Recombinant), Porcine Sequence] for the treatment of bleeding episodes in adults with acquired hemophilia A (acquired Factor VIII [FVII] deficiency).
Modified Gene Therapy May Help Children With SCID
Children with SCID have a hard time fighting infections, and, sometimes, treatment for their disease makes them even sicker. But a new therapy for these kids has shown good results in fighting SCID and may prevent one serious side effect of treatment.
Common Medicines May Increase Blood Clot Risk
When dealing with a headache or other pain, many people reach for over-the-counter pain relievers like naproxen or ibuprofen. But these types of medication, known as non-steroidal anti-inflammatory drugs (NSAIDS), could come with an increased risk of blood clots.
Mother’s Iron Level Tied to Child’s Autism Risk
Iron deficiency has been associated with autism in past studies, such as one published in Pediatrics in 2012. And children of mothers who have too little iron during pregnancy may also have a higher risk of getting this condition.
FDA Approves Rx for Severe Aplastic Anemia
GlaxoSmithKline plc (GSK) announced today that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for the once-daily use of Promacta® (eltrombopag) in patients with severe aplastic anaemia (SAA) who have had an insufficient response to immunosuppressive therapy (IST).
Aspirin Effective for Clot Prevention in Certain Patients
New research suggests that aspirin may be a safe alternative for those who have to stop taking anti-blood-clotting medicines.
FDA Expands Approval of Rx for Rare Blood and Bone Disease
Earlier this year, the US Food and Drug Administration (FDA) gave a speedy approval to a new medication to treat a rare blood disease. Now, the FDA has expanded that approval.